D-0583-2020 Class II Terminated
FDA drug recall D-0583-2020 was initiated by Coast Quality Pharmacy, LLC Dba Anazao Health on Sep 3, 2019 and is designated Class II. Reason for recall: Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi. The recall status is terminated (terminated Dec 1, 2020).
Recall details
- Product Type
- Drugs
- Report Date
- Dec 18, 2019
- Initiation Date
- Sep 3, 2019
- Termination Date
- Dec 1, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Bupivacaine HCL and Clonidine HCL and Hydromorphone HCL in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.
Reason for recall
Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.
Distribution pattern
Nationwide in the U.S.
Code information
All lots filled 08/26/2019 and dispensed 08/26-29/2019 remaining within expiry.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0583-2020
- openFDA file date
- Nov 17, 2026
- Loaded by RegDataLab
- Nov 18, 2026